CD4 and Hypertension: In a cohort of 816 PLWH who started ART in 2005–2008 at GHESKIO, 5.3% had hypertension at the time of ART initiation, and this independently predicted mortality during 10 years of follow-up (HR 2.47 [95% CI 1.10–5.57]), after adjusting for age, sex, CD4 count at ART start [13].